You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Haploidentical stem cell transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)

Recruiting
  • Sickle Cell Disease
  • Hematopoietic stem cell transplantation
  • Duarte, California
    City of Hope Medical Center
Jun 14, 2022

Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)

Recruiting
  • Relapsed Hematologic Malignancy
  • donor-derived CIK cells
  • Bergamo, Italy
    A O Papa Giovanni XXIII
Dec 22, 2021

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Haplo SCT with NK cells
  • Haplo SCT
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

Active, not recruiting
  • Hodgkin's Lymphoma
  • +8 more
  • Reduced intensity haplodentical stem cell transplant
  • Myeloablative haploidentical stem cell transplant
  • Birmingham, United Kingdom
  • +11 more
Sep 27, 2021

Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Blood and Marrow Transplant
  • Minneapolis, Minnesota
    Masonic Caner Center at University of Minnesota
May 23, 2022

Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic

Not yet recruiting
  • Refractory Idiopathic Aplastic Anemia
  • Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
  • Allogenic transplantation
  • (no location specified)
Nov 8, 2021

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT

Recruiting
  • CMV Infection
  • Hematopoietic Stem Cell Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Mar 29, 2023

Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)

Not yet recruiting
  • Hematologic Diseases
  • +2 more
  • haplo-SCT with PTCy
  • (no location specified)
Nov 8, 2021

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • EAGD T-cell infusion (Phase I)
  • EAGD T-cell infusion (Expansion)
  • Westwood, Kansas
    University of Kansas Cancer Center
Mar 15, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Sickle Cell Disease Trial (Haploidentical stem cell transplantation, Standard medical care)

Not yet recruiting
  • Sickle Cell Disease
  • Haploidentical stem cell transplantation
  • Standard medical care
  • (no location specified)
May 23, 2022